Fig. 2From: Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern AfricaG6PD genotype prevalence. a G6PD genotypes (B patterned bar; A+ (A375G) white bar; A− (A375G/G202A) heterozygous light grey bar, hemizygous and homozygous dark grey bar) identified with PCR–RFLP and confirmed by sequencing for all the study participants. b G6PD deficiency stratified for each of the 6 primary health care clinics in Vhembe District, Limpopo Province, South Africa. (B patterned wedge; A+ (A375G) white wedge; A− (A375G/G202A) heterozygous light grey wedge, hemizygous and homozygous dark grey wedge)Back to article page